Current stock page

Financial Data

OMER Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

OMEROmeros Corporation

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 7/10
$17.49−$0.50 (−2.78%)

Latest quote

  • Momentum
    79
  • Value
    73
  • Quality
    55
  • Risk resilience
    33
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$28.53M$9.89M$0$0$0$0$0$0
Gross Profit$27.73M$9.07M$0$0-$10.29M$0-$301K$0
Operating Income$74K-$17.42M-$29.08M-$26.39M-$32.35M-$34.97M-$35.66M-$35.41M
Net Income$13.23M$56.06M$86.45M-$30.92M-$25.42M-$33.46M-$31.36M-$32.23M
EPS$0.18$0.78$1.42-$0.47-$0.43-$0.58-$0.54-$0.56
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$4.15M-$14.51M-$39.84M-$18.47M-$21.94M-$35.84M-$28.98M-$32.06M
Capital Expenditure-$45K$0$0-$11K-$13K-$41K-$26K-$1K
Free Cash Flow$4.1M-$14.51M-$39.84M-$18.48M-$21.95M-$35.88M-$29.01M-$32.06M
Net Cash Provided By Operating Activities$4.15M-$14.51M-$39.84M-$18.47M-$21.94M-$35.84M-$28.98M-$32.06M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$286.83M$286.17M$325.63M$185.71M$200.57M$235.16M$277.08M$313.34M
Total Debt$83.77M$310.63M$239.14M$191.61M$184.33M$415.05M$207.02M$209.47M
Cash And Cash Equivalents$1.99M$1.91M$9.66M$2.4M$1.9M$4.26M$3.4M$1.52M
Total Liabilities$338.18M$349.51M$446.86M$406.18M$429.25M$448.71M$459.69M$467.51M
Total Stockholders Equity-$51.35M-$63.33M-$121.23M-$220.48M-$228.69M-$213.55M-$182.61M-$154.17M
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio9.8415.04——————
P/B ratio————————
P/S ratio32.83———————
Debt To Equity————————
Free Cash Flow Yield-5.59%-7.31%-17.32%-25.31%-49.26%-62.36%-34.84%-27.17%
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio9.8415.04——————
P/B ratio————————
P/S ratio32.83———————
Return On Equity————————
Debt To Equity————————

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe9.16x
Pb-24.57x
EPS Growth Yoy141.86%
Gross Margin95.77%
Operating Margin-189.53%
ROE-109.40%
ROIC-31.14%
Debt To Equity-1.63
FCF Yield-5.43%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$17.49
Volume737,384
RSI (14)47.88
MACD-0.1
MACD signal-0.14
MACD histogram0.04
ADX (14)12.19
SMA (50)$18.27
SMA (200)$13.77
ATR (14)$0.90
Historical volatility (annualized)54.89%
Volume (20-day average)976,464

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score33/100
Beta1.6
Annual volatility110.84%
Max Drawdown-49.52%
Sharpe Ratio1.36
VaR (95%, 1-day)-6.67%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

OMER Financial Data FAQ

What is Omeros Corporation's revenue?

Omeros Corporation's revenue is one of the core financial data points for OMER. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Omeros Corporation's revenue growing?

Revenue growth shows whether Omeros Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is OMER's EPS?

OMER's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Omeros Corporation's net income?

Omeros Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Omeros Corporation generate?

Free cash flow shows how much cash Omeros Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Omeros Corporation have?

Cash and debt help frame OMER's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.